Downregulation of UBE2C depresses the ATG3 and LC3 and dramatically decreases cancer cell invasive growth, migration, and EMT phonotypic switching while enhancing apoptosis and cell cycle of NSCLC (Fig. 3c−f). This evidence concerns the gene UBE2C and cancer.